SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Charlotte Sueur, Julien Lupo, Philippe Mas, Patrice Morand, Véronique Boyer, Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line, Virology Journal, 2014, 11, 1, 94

    CrossRef

  2. 2
    Yuxuan Liu, Ahmad Sattarzadeh, Arjan Diepstra, Lydia Visser, Anke van den Berg, The microenvironment in classical Hodgkin lymphoma: An actively shaped and essential tumor component, Seminars in Cancer Biology, 2014, 24, 15

    CrossRef

  3. 3
    P. Greaves, A. Clear, A. Owen, S. Iqbal, A. Lee, J. Matthews, A. Wilson, M. Calaminici, J. G. Gribben, Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells, Blood, 2013, 122, 16, 2856

    CrossRef

  4. 4
    V Bohle, C Döring, M-L Hansmann, R Küppers, Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma, Leukemia, 2013, 27, 3, 671

    CrossRef

  5. 5
    Robert E. White, Patrick C. Rämer, Kikkeri N. Naresh, Sonja Meixlsperger, Laurie Pinaud, Cliona Rooney, Barbara Savoldo, Rita Coutinho, Csaba Bödör, John Gribben, Hazem A. Ibrahim, Mark Bower, Jamie P. Nourse, Maher K. Gandhi, Jaap Middeldorp, Fathima Z. Cader, Paul Murray, Christian Münz, Martin J. Allday, EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors, Journal of Clinical Investigation, 2012, 122, 4, 1487

    CrossRef

  6. 6
    Claudia Otto, Maciej Giefing, Anne Massow, Inga Vater, Stefan Gesk, Matthias Schlesner, Julia Richter, Wolfram Klapper, Martin-Leo Hansmann, Reiner Siebert, Ralf Küppers, Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma, British Journal of Haematology, 2012, 157, 6
  7. You have open access to this content7
    Kosuke Miyauchi, Emiko Urano, Hironori Yoshiyama, Jun Komano, Cytokine signatures of transformed B cells with distinct Epstein–Barr virus latencies as a potential diagnostic tool for B cell lymphoma, Cancer Science, 2011, 102, 6
  8. 8
    Lee Machado, Ruth Jarrett, Susan Morgan, Paul Murray, Beatrix Hunter, Emma Hamilton, John Crocker, Wendy Thomas, Neil Steven, Tariq Ismail, Ann Chapman, David H. Adams, Steven P. Lee, Expression and function of T cell homing molecules in Hodgkin’s lymphoma, Cancer Immunology, Immunotherapy, 2009, 58, 1, 85

    CrossRef

  9. 9
    A. Di Stasi, B. De Angelis, C. M. Rooney, L. Zhang, A. Mahendravada, A. E. Foster, H. E. Heslop, M. K. Brenner, G. Dotti, B. Savoldo, T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model, Blood, 2009, 113, 25, 6392

    CrossRef

  10. 10
    Sumio Takegawa, Zhe Jin, Takashi Nakayama, Takashi Oyama, Kunio Hieshima, Daisuke Nagakubo, Aiko-Konno Shirakawa, Toyonori Tsuzuki, Shigeo Nakamura, Osamu Yoshie, Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein–Barr virus-associated B-cell lymphoproliferative disorder, Cancer Science, 2008, 99, 2
  11. 11
    Donatella Aldinucci, Debora Lorenzon, Lara Cattaruzza, Antonio Pinto, Annunziata Gloghini, Antonino Carbone, Alfonso Colombatti, Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions, International Journal of Cancer, 2008, 122, 4
  12. 12
    Karl R.N. Baumforth, Anna Birgersdotter, Gary M. Reynolds, Wenbin Wei, Georgia Kapatai, Joanne R. Flavell, Emma Kalk, Karen Piper, Steve Lee, Lee Machado, Kerry Hadley, Anne Sundblad, Jan Sjoberg, Magnus Bjorkholm, Anna A. Porwit, Lee-Fah Yap, Soohwang Teo, Richard G. Grundy, Lawrence S. Young, Ingemar Ernberg, Ciaran B.J. Woodman, Paul G. Murray, Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells, The American Journal of Pathology, 2008, 173, 1, 195

    CrossRef

  13. 13
    V. Brune, E. Tiacci, I. Pfeil, C. Doring, S. Eckerle, C. J.M. van Noesel, W. Klapper, B. Falini, A. von Heydebreck, D. Metzler, A. Brauninger, M.-L. Hansmann, R. Kuppers, Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis, Journal of Experimental Medicine, 2008, 205, 10, 2251

    CrossRef

  14. 14
    Y. Ma, L. Visser, H. Roelofsen, M. de Vries, A. Diepstra, G. van Imhoff, T. van der Wal, M. Luinge, G. Alvarez-Llamas, H. Vos, S. Poppema, R. Vonk, A. van den Berg, Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes, Blood, 2008, 111, 4, 2339

    CrossRef

  15. 15
    Christian Koenecke, Sya N Ukena, Arnold Ganser, Anke Franzke, Regulatory T cells as therapeutic target in Hodgkin's lymphoma, Expert Opinion on Therapeutic Targets, 2008, 12, 6, 769

    CrossRef

  16. 16
    Marijke Niens, Lydia Visser, Ilja M. Nolte, Gerrit Van Der Steege, Arjan Diepstra, Pablo Cordano, Ruth F. Jarrett, Gerard J. Te Meerman, Sibrand Poppema, Anke Van Den Berg, Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22, British Journal of Haematology, 2008, 140, 5
  17. 17
    J. Haas, L. Schopp, B. Storch-Hagenlocher, B. Fritzsching, C. Jacobi, L. Milkova, B. Fritz, A. Schwarz, E. Suri-Payer, M. Hensel, B. Wildemann, Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis, Blood, 2008, 111, 2, 761

    CrossRef

  18. 18
    Yue Ma, Lydia Visser, Tjasso Blokzijl, Geert Harms, Çiǧdem Atayar, Sibrand Poppema, Anke van den Berg, The CD4+CD26− T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile, Laboratory Investigation, 2008, 88, 5, 482

    CrossRef

  19. 19
    Takashi Ishida, Ryuzo Ueda, CCR4 as a novel molecular target for immunotherapy of cancer, Cancer Science, 2006, 97, 11
  20. 20
    Martina Vockerodt, Diana Pinkert, Sigrun Smola-Hess, Astrid Michels, Richard M. Ransohoff, Hans Tesch, Dieter Kube, The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: Importance of mRNA half-life regulation, International Journal of Cancer, 2005, 114, 4
  21. 21
    Hitoshi Hanamoto, Takashi Nakayama, Hajime Miyazato, Sumio Takegawa, Kunio Hieshima, Yoichi Tatsumi, Akihisa Kanamaru, Osamu Yoshie, Expression of CCL28 by Reed-Sternberg Cells Defines a Major Subtype of Classical Hodgkin's Disease with Frequent Infiltration of Eosinophils and/or Plasma Cells, The American Journal of Pathology, 2004, 164, 3, 997

    CrossRef

  22. 22
    S. Ranganathan, Ronald Jaffe, Is there a difference between Hodgkin's disease and a Hodgkin's-like post-transplant lymphoproliferative disorder, and why should that be of any interest?, Pediatric Transplantation, 2004, 8, 1
  23. 23
    Marie Fischer, Mikael Juremalm, Niclas Olsson, Carin Backlin, Christer Sundström, Kenneth Nilsson, Gunilla Enblad, Gunnar Nilsson, Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue, International Journal of Cancer, 2003, 107, 2
  24. 24
    Loránd L. Kis, Noémi Nagy, George Klein, Eva Klein, Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines, International Journal of Cancer, 2003, 104, 5
  25. 25
    Ewerton M. Maggio, Anke van den Berg, Debora de Jong, Arjan Diepstra, Sibrand Poppema, Low Frequency of FAS Mutations in Reed-Sternberg Cells of Hodgkin's Lymphoma, The American Journal of Pathology, 2003, 162, 1, 29

    CrossRef

  26. 26
    Anna Maria Elisabeth Walenkamp, Bacterial Proteins against Metastasis,